Cardiology Product Guide » Everolimus Eluting Coronary Stent System http://blog.cardiologyproductguide.com A comprehensive guide to cardiology products for medical professionals Tue, 14 Jun 2011 11:39:11 +0000 en hourly 1 http://wordpress.org/?v=3.1.3 Abbott’s XIENCE V(R) Approved In Japan – Second Largest Drug Eluting Stent Market Worldwide http://blog.cardiologyproductguide.com/2010/01/12/abbotts-xience-vr-approved-in-japan-second-largest-drug-eluting-stent-market-worldwide/ http://blog.cardiologyproductguide.com/2010/01/12/abbotts-xience-vr-approved-in-japan-second-largest-drug-eluting-stent-market-worldwide/#comments Tue, 12 Jan 2010 06:09:37 +0000 admin http://www.cardiologyproductguide.com/blog/?p=219 AbbottAbbott announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V (R) Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. Japan is the second largest drug eluting stent market in the world after the United States, with approximately 200,000 stent procedures performed each year. The company plans to launch XIENCE V in Japan in the upcoming weeks, immediately following final reimbursement authorization.

For the full story, Click Here

]]> http://blog.cardiologyproductguide.com/2010/01/12/abbotts-xience-vr-approved-in-japan-second-largest-drug-eluting-stent-market-worldwide/feed/ 0